Stocktoria
Inmune Bio, Inc. INMB
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2019-02-04
Inmune Bio, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 812,895 | $7.2M | 3.06% |
| AQR CAPITAL MANAGEMENT LLC | 270,317 | $305,458 | 1.02% |
| RENAISSANCE TECHNOLOGIES LLC | 17,000 | $19,210 | 0.06% |
| CITADEL ADVISORS LLC | 12,500 | $14,125 | 0.05% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.